COVID-19 vaccine maker Moderna gets net profit for first time
Finance
- 08 May, 2021
- 11:20

For the first time in its history (since 2010), COVID-19 vaccine maker Moderna, an American biotech company, received a net profit of $ 1.2 billion in the first quarter of 2021.
In the first quarter of 2020, the company posted a net loss of USD 124 million. Moderna's revenue in January-March 2021 was USD 1.9 billion ($ 8 million for the same period last year). Of this amount, $ 1.7 billion is the proceeds from the sale of coronavirus vaccines.
By the end of this year, Moderna intends to produce 1 billion doses, and next year - 3 billion doses.
Latest News
17:55
British Ambassador to Azerbaijan Fergus Auld visits Lachin
Foreign policy17:48
Barcelona register Wojciech Szczesny ahead of Rayo Vallecano clash
Football17:39
MEDIA, China's Xinhua News Agency sign Memorandum of Understanding
Media17:33
Israel targeted top Iranian leaders by hacking, tracing their bodyguards' phones
Other countries17:17
Trump confident trilateral summit involving Russia, US, Ukraine will take place
Other countries17:05
Israeli jets carry out eight raids on Hezbollah targets in southern Lebanon
Other countries16:43
US administration plans to rebrand Pentagon as 'Department of War' — newspaper
Other countries16:22
Turkish president: 'We are pleased with development of relations between Pakistan, Northern Cyprus'
Region16:01